ALOX15 and fatty liver disease: A study of whole‐body Alox15−/− mice under a HFD revealed a decrease in lymphocyte infiltration and pro‐inflammatory mRNA levels of TNFα and IFN‐γ, thereby protecting against hepatic steatosis [30].